Tag Archives: GlaxoSmithKline

As GlaxoSmithKline works to get Shingrix back on track, an FDA approval increases the key vaccine’s reach

In response to the coronavirus pandemic knocking Shingrix off its juggernaut course, GlaxoSmithKline plans a “relaunch” to get the rising star vaccine back on its upward trajectory. Now, that effort has received a boost as the FDA on Monday approved the shingles vaccine in adults age 18 and older who are immunocompromed and thus are at a greater… Read More »